Clinical Trial Update: Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects [Phase 1, Phase 2]

View source ↗

Summary

Pediatric phase 1/2 trial evaluating itacitinib in combination with corticosteroids for acute graft-versus-host disease; the study was terminated and results ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Itacitinib (itacitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Acute Graft-versus-host Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-02-21